Snowmass Ophthalmology

Victor H. Gonzalez, MD Valley Retina Institute McAllen, Texas David H. Brown Retina Consultants of Houston Tom M. Schossau, MD, MEng-Physics Louis B. Cantor, MD Ronald Frenkel, MD Anna K. Junk, M.D. John Samples, MD Michael Tolentino, MD
|
| Time | Moderator | Speaker | Date |
| Mon 3-12 | |||
| 7:45-8:00 a.m. | Frenkel | Frenkel | Course Introduction |
| 8:00-9:00 a.m. | Tolentino | Genetics of AMD and how you can use it in the office | |
| 4:15-5:15 p.m. | Gonzalez | Tolentino | Inflammation in AMD why it is important |
| 5:15-6:00 p.m. | Frenkel | Eylea-- Results and Panel Discussion | |
| 6:00-6:30 p.m. | Gonzalez | Lessons on management of AMD from current clinical trials. Can we do better? | |
| 6:30-6:45 p.m. | Gonzalez | The Role of Diagnostic Imaging in Staging and Managing Retinitis Pigmentosa | |
| Tues 3-13 | |||
| 7:45-8:30 a.m. | Dyer | Tolentino | Antioxidation in AMD or what your patients should be taking |
| 8:30-8:45 a.m. | Gonzalez | Endoscope as Adjunct for Retina Surgery | |
| 8:45-9:00 a.m. | Schossau | New Keratome for Cataract Surgery | |
| 4:15-5:00 p.m. | Tolentino | Tolentino | Eyedrops for Wet AMD how far along are we? |
| 5:00-5:45 p.m. | Frenkel | Update on Retinal Vein Occlusions | |
| 5:45-6:15 p.m. | Dyer | Advances in Telemedicine for Retinal Disease | |
| 6:15-6:45 p.m. | Gonzalez | Management of Diabetic Retinopathy 2012. | |
| Wed 3-14 | |||
| 8:00-9:00 a.m. | Frenkel | Cantor | Glaucoma Surgery Complications |
| 4:15-4:30 p.m. | Cantor | Suhr | Progressive Normal Tension Glaucoma despite low IOP |
| 4:30-5:30 p.m. | Cantor | Neuroprotection | |
| 5:30- 6:00 p.m. | Cantor | The role of generics in glaucoma medical therapy | |
| 6:00-6:45 p.m. | Gordon | EMR and group discussion | |
| Thurs 3-15 | |||
| 7:45-8:30 a.m. | Frenkel | Brown | Retinal Imaging Update |
| 8:30-9:00 a.m. | Brown | Pre-proliferative Vein Occlusions | |
| 4:15-4:45 p.m. | Junk | Junk | Glaucoma Drainage Devices |
| 4:45-5:30 p.m. | Samples | The 2nd visual system: Photosensitive retinal ganglion cells and melatonin | |
| 5:30-6:00 p.m. | Samples | Genes and loci for open angle glaucoma: Endophenotype and ASB10 | |
| 6:00-6:45 p.m. | Wirostko | Clinical Drug Development/Novel IOP Lowering Agents /Rho Kinase Inhibitors | |
| Fri 3-16 | |||
| 8:00-9:00 a.m. | Frenkel | Samples | New considerations in the evolving surgical pipeline for glaucoma |
| 4:30-5:00 p.m. | Samples | Junk | SD OCT to Differentiate Glaucoma from other Optic Neuopathies |
| 5:00-5:30 p.m. | Frenkel | Effect on IOP of Anti-VEGF Treatments | |
| 5:30-6:30p .m. | Samples | The new trabecular treatments: Stem cells, rho kinase inhibitors, adenyl cyclase drugs | |
| 6:15-6:45 p.m. | tbd |